Gerald Schrenk

About

Seasoned life sciences leader with over 20 years of experience in preclinical/clinical research, CMC product development, scientific strategy, and medical affairs collaboration. Combines deep expertise in plasma‑derived and recombinant therapeutics with a strong track record of driving complex R&D programs, supporting regulatory and clinical activities, and ensuring scientific consistency across internal and external stakeholders. Known for exceptional communication and influencing skills, impactful congress contributions, and strong relationships with physicians and KOLs. Brings scientific rigor, strategic thinking, and the ability to align diverse clinical, regulatory, and cross‑functional partners in matrixed environments.

Experience

• Takeda (7 yrs 7 mos)
  • Head of Potency Assays and Functional Characterization. Analytical Development EU
    Mar 2023 - Present · 3 yrs 5 mos

  • Head of Functional Sciences, Analytical Development Biologics EU/ Pharmaceutical Sciences
    Dec 2019 - Feb 2023 · 3 yrs 3 mos

  • Associate Director, Lead Hemophilia R&D
    Jan 2019 - Nov 2019 · 11 mos

• Shire (2 yrs 8 mos)
  • Associate Director, Lead Hemophilia R&D
    Feb 2017 - Jan 2019 · 2 yrs

  • Manager Hemophilia Exploratory, Research and Nonclinical Development
    Jun 2016 - Jan 2017 · 8 mos

• Manager Hemophilia Exploratory R&D at Baxalta
  Apr 2014 - May 2016 · 2 yrs 2 mos

• Baxter International Inc. ()
  • Manager R&D Hemophilia
    Apr 2012 - Mar 2014 · 2 yrs

  • Research Scientist
    Jul 2004 - Mar 2012 · 7 yrs 9 mos

• Internship Dept. Biochemistry at Universität Wien
  Nov 2002 - Mar 2003 · 5 mos